Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4009 Target Snapshot

DNA polymerase catalytic subunit · SINGLE PROTEIN · Human herpesvirus 6A (strain Uganda-1102) (HHV-6 variant A) (Human Blymphotropic virus)

36Compounds
1Assays
0Approved Drugs
36.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P28857. Use UniProt P28857 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P28857 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats DNA polymerase catalytic subunit as ChEMBL target CHEMBL4009, mapped to UniProt P28857. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
DNA polymerase catalytic subunit
SINGLE PROTEIN · Human herpesvirus 6A (strain Uganda-1102) (HHV-6 variant A) (Human Blymphotropic virus)
As of 2026-09-14
ChEMBL target ID
CHEMBL4009
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P28857
DNA polymerase catalytic subunit
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether DNA polymerase catalytic subunit is the right protein anchor across sources, using UniProt P28857 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDNA polymerase catalytic subunit
UniProt AccessionP28857
Component TypeProtein
Sequence Length1012 aa

DNA polymerase catalytic subunit

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as DNA polymerase catalytic subunit, mapped to UniProt P28857. Sequence length is 1012 aa.

Mapped IDP28857
Review nameDNA polymerase catalytic subunit
OrganismHuman herpesvirus 6A (strain Uganda-1102) (HHV-6 variant A) (Human Blymphotropic virus)
Assay Mix

Activity Type Distribution

IC5036.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL29711 6.4 IC50 400.0 Preclinical
CHEMBL66078 6.12 IC50 760.0 Preclinical
CHEMBL62295 6.09 IC50 820.0 Preclinical
CHEMBL62784 5.62 IC50 2400.0 Preclinical
CHEMBL65757 5.62 IC50 2400.0 Preclinical
CHEMBL66188 5.54 IC50 2900.0 Preclinical
CHEMBL292775 5.48 IC50 3300.0 Preclinical
CHEMBL66652 5.42 IC50 3800.0 Preclinical
CHEMBL418669 5.4 IC50 4000.0 Preclinical
CHEMBL63201 5.22 IC50 6000.0 Preclinical
Distribution

pChEMBL Value Distribution

6
5.0
3
5.5
3
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

1
Total Assays
25
Tested Compounds
1
Assay Types
Binding — 1 assays, 25 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 25 5.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine